JHS Svendgaard Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve un-audited Financial ....
JHS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JHS Svendgaard Laboratories has informed BSE and NSE that its Board of Directors will meet on Thursday, November 13, 2025, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. The company has also closed its trading window from October 1, 2025, until 48 hours after the results are announced, in line with insider trading regulations. The intimation has been filed under SEBI LODR Regulation 29(1)(a) on November 7, 2025, by Company Secretary Komal Jha.
This is a routine pre-results announcement and does not directly impact shareholders or the stock price. Investors should watch the November 13 results for actual financial performance, as Q2 numbers could influence short-term sentiment in the stock.